| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/19/2000 | EP1020529A2 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
| 07/19/2000 | EP1020439A1 Cetp activity inhibitors |
| 07/19/2000 | EP1020187A1 Pharmaceutical compositions containing hydroximic acid derivatives |
| 07/19/2000 | EP1019515A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumour treatment |
| 07/19/2000 | EP1019490A2 Methods for modulating hematopoiesis and vascular growth |
| 07/19/2000 | EP1019434A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 07/19/2000 | EP1019427A1 N?6 -substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| 07/19/2000 | EP1019426A1 Novel a 1? adenosine receptor agonists and antagonists |
| 07/19/2000 | EP1019412A1 Biphenyl(thio)amide and biphenylethan(thi)one derivatives, their preparation and their use as 5-ht 1d? receptor antagonists |
| 07/19/2000 | EP1019409A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 07/19/2000 | EP1019408A1 1,2,3,4-TETRAHYDRO-BENZOFURO 3,2-c]PYRIDINE DERIVATIVES-- |
| 07/19/2000 | EP1019406A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 07/19/2000 | EP1019396A1 Novel cycloalkyl substituted imidazoles |
| 07/19/2000 | EP1019394A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS |
| 07/19/2000 | EP1019391A1 Inhibitors of prenyl-protein transferase |
| 07/19/2000 | EP1019384A1 3-amino-1,2-benzoisoxazole derivatives, process for preparation, and use thereof |
| 07/19/2000 | EP1019380A2 Tricyclic 3-oxo-propanenitrile compounds |
| 07/19/2000 | EP1019373A1 Novel human nk 3? receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 07/19/2000 | EP1019370A1 Ace-inhibitor nitric salts |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019089A2 Long-acting drugs and pharmaceutical compositions comprising them |
| 07/19/2000 | EP1019082A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019073A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 07/19/2000 | EP1019071A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 07/19/2000 | EP1019055A1 Endothelin antagonist and beta receptor blocking agent as combined preparations |
| 07/19/2000 | EP1019048A1 Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients |
| 07/19/2000 | EP1019045A1 Antithrombotic agents |
| 07/19/2000 | EP1019040A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS |
| 07/19/2000 | EP1019034A2 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 07/19/2000 | EP1019010A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 07/19/2000 | EP1018965A1 Method of treating the syndrome of coronary heart disease risk factors in humans |
| 07/19/2000 | EP1018878A1 Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain |
| 07/19/2000 | EP0760819B1 Tricyclic dicarbonyl derivatives |
| 07/19/2000 | EP0674626B1 Selective aromatase inhibiting compounds |
| 07/19/2000 | EP0514452B2 Use of insulin sensitizing agents to treat hypertension |
| 07/19/2000 | CN1260835A Truncated vegf-related proteins |
| 07/19/2000 | CN1260801A Novel glycosylated ginkgolide derivatives, their applicated as medicines and pharmaceutical compositions |
| 07/19/2000 | CN1260798A Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha 1-blocking action |
| 07/19/2000 | CN1260794A 5-aryl-3-(8-azabicyclo (3.2.2) oct-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives as -5HT4 receptor ligands |
| 07/19/2000 | CN1260791A 3-benzylpiperidine |
| 07/19/2000 | CN1260789A Heterocyclic compounds, method for preparing and medicine compositions containing same |
| 07/19/2000 | CN1260784A Quinoline derivatives as PDEIV and INF inhibitors |
| 07/19/2000 | CN1260780A Ace-inhibitor nitric salts |
| 07/19/2000 | CN1260778A Prostaglandin pharmaceutical compositions |
| 07/19/2000 | CN1260193A Medicinal composition for stasis of blood |
| 07/19/2000 | CN1054599C Hydroxamic acid derivatives and preparation method and use |
| 07/19/2000 | CN1054529C Slow-release adhesive film for treating caronary heart disease and preparation method thereof |
| 07/18/2000 | US6090981 Antiarrhythmics. |
| 07/18/2000 | US6090944 Alkanoic acid derivatives as αv integrin receptor antagonists |
| 07/18/2000 | US6090852 Matrix metalloprotease inhibitor |
| 07/18/2000 | US6090849 Carnitine supplemented diet to prevent sudden death syndrome in breeder type poultry |
| 07/18/2000 | US6090845 Hypotensive agent; vision defects |
| 07/18/2000 | US6090840 Peptidyl compounds having MMP and TNF inhibitory activity |
| 07/18/2000 | US6090826 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 07/18/2000 | US6090825 Oxazole derivatives as antagonists of alpha 1C andrenergic receptors |
| 07/18/2000 | US6090818 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them |
| 07/18/2000 | US6090813 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 07/18/2000 | US6090808 Dimeric piperidine, tetrahydropyridine and piperazine derivatives |
| 07/18/2000 | US6090779 Use of hemoglobin to treat septic shock |
| 07/18/2000 | US6090777 Administering exogenous c1-esterase inhibitor, alone or with other drugs to a patient with acute myocardial infarction or at risk for acute myocardial infarction |
| 07/18/2000 | US6090775 Treatment of neurological conditions by an interleukin-1 inhibiting compound |
| 07/18/2000 | US6090618 DNA constructs and viral vectors comprising a smooth muscle promoter |
| 07/18/2000 | US6090612 Polynucleotide sequence coding a phosphatase enzymes; a diagnostic tool for monitoring enzyme activity in sample; for treatment of nervous system disorders, cardiovascular disorders and tumors; antitumor agents |
| 07/18/2000 | US6090579 Human SDR2 cDNA clone |
| 07/18/2000 | US6090544 Screening for compounds capable of activating osteogenic protein-1-responsive transcription activating element by transforming cell with dna of element linked to reporter gene, exposing cell to compound, determining gene expression |
| 07/18/2000 | US6090410 Dry mix formulation for bisphosphonic acids |
| 07/18/2000 | US6090382 Human antibodies that bind human TNFα |
| 07/18/2000 | CA2008616C Aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions |
| 07/13/2000 | WO2000040737A1 High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site |
| 07/13/2000 | WO2000040733A1 Human cyclic nucleotide pdes |
| 07/13/2000 | WO2000040716A2 Soluble receptor br43x2 and methods of using them for therapy |
| 07/13/2000 | WO2000040714A2 Therapeutic phosphodiesterase inhibitors |
| 07/13/2000 | WO2000040699A2 Astrocytes, their preparation and uses thereof |
| 07/13/2000 | WO2000040613A1 Insulin-like growth factor (igf) i mutant variants |
| 07/13/2000 | WO2000040612A1 Insulin-like growth factor (igf) i mutant variants |
| 07/13/2000 | WO2000040600A1 Selective inhibitors of mmp-12 |
| 07/13/2000 | WO2000040597A1 Method and composition for angiogenesis inhibition |
| 07/13/2000 | WO2000040584A2 Process for preparing n6-substituted deaza-adenosine derivatives |
| 07/13/2000 | WO2000040583A2 Imidazo[4,5-c]-pyridine-4-on-derivatives |
| 07/13/2000 | WO2000040578A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase |
| 07/13/2000 | WO2000040576A2 Thiopyran compounds as inhibitors of mmp |
| 07/13/2000 | WO2000040574A1 1,4-diazacycloheptane compounds, process for their preparation, and their use as medicaments |
| 07/13/2000 | WO2000040571A1 Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity) |
| 07/13/2000 | WO2000040569A1 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 07/13/2000 | WO2000040560A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 07/13/2000 | WO2000040548A1 Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 07/13/2000 | WO2000040529A1 Colchinol derivatives as vascular damaging agents |
| 07/13/2000 | WO2000040247A1 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 07/13/2000 | WO2000040243A1 Novel compounds |
| 07/13/2000 | WO2000040241A2 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 07/13/2000 | WO2000040239A1 Compounds and methods |
| 07/13/2000 | WO2000040232A2 Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions |
| 07/13/2000 | WO2000040226A2 Method of treating sexual disturbances |
| 07/13/2000 | WO2000040225A2 Inhibition of tnf activity |
| 07/13/2000 | WO2000040172A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 07/13/2000 | WO2000040086A1 Formulations for treating disease and methods of using same |
| 07/13/2000 | WO2000027363B1 Aerosols comprising nanoparticle drugs |
| 07/13/2000 | WO2000025764A3 Compositions for the treatment and prevention of cardiovascular diseases |
| 07/13/2000 | WO2000024897B1 Cell surface molecule-induced macrophage activation |